Nearly 8 percent of hip implants not backed by safety evidence

December 19, 2013, British Medical Journal

Almost 8 percent of all implants used in hip replacement surgery have no readily available evidence relating to their safety or effectiveness, finds a study published in BMJ today.

The researchers say the current regulation process "seems to be entirely inadequate" and they call for a revised system for introducing new orthopaedic devices.

The high failure rate of some metal-on-metal hip replacements has highlighted the need for an adequate evidence base for . Many implants are available to orthopaedic surgeons, but it is not known how many of these have evidence of to support their use.

So researchers based at the University of Oxford set out to establish the number of joints that have no readily available evidence of clinical effectiveness to support their use – and how many are being implanted in clinical practice.

Using data from the National Joint Registry (NJR) of England and Wales, they identified implants used in in 2011 that were rated "unclassified" or "pre-entry" by the Orthopaedic Data Evaluation Panel (ODEP) – the body that rates implants according to levels of evidence.

Implants termed "unclassified" have had no evidence submitted by the manufacturers, while "pre-entry" products have less than three years of evidence. Yet many are widely available for implantation by an .

The team then reviewed the medical literature to establish the level of evidence available for these implants.

The review showed that 10,402 (7.6%) of the 136,593 components used in primary hip replacements in 2011 were implanted without readily identifiable evidence of clinical effectiveness. These comprised 157 cemented stems (0·5% of those implanted), 936 uncemented stems (2.8%), 1,732 cemented cups (7.1%), and 7,577 uncemented cups (17.1%).

This is of great concern, say the authors, "particularly in light of the widespread publicity surrounding recent safety problems with regard to some resurfacing and other large diameter metal-on-metal joint replacements."

This is also likely to be an underestimation of the true problem, "as much of the evidence that does exist for the other unrated prostheses is of low quality or relates to short-term outcomes only," they add.

They suspect that the paucity of good quality evidence in this area may be related to the rapid expansion in the number of devices introduced onto the market during the past two decades, as demand for hip increases worldwide, and the difficulty of conducting high quality randomised controlled trials with orthopaedic .

"This study shows that the need still exists for an improved and more rigorous approach to regulation of devices to avoid devices with no available evidence being used in a widespread and uncontrolled manner," they conclude.

In an accompanying editorial, researchers at Harvard Medical School argue that "the ability of manufacturers to promote devices or drugs that are authorized by regulators for widespread use but that do not have rigorous pre-approval data should be restricted."

They add: "physicians who adopt new technologies that have little or no evidence of superiority over existing products need to be educated about the implications of their choices. They should also ensure that their patients know about the benefits and risks of the new - but often unproved - medical devices that they are receiving."

Explore further: New hip implants no better than traditional implants

More information: www.bmj.com/cgi/doi/10.1136/bmj.f6956
www.bmj.com/cgi/doi/10.1136/bmj.f7413

Related Stories

New hip implants no better than traditional implants

November 30, 2011
New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published in the British Medical Journal today.

US company to pay $2.5B in hip replacement suits (Update)

November 19, 2013
Johnson & Johnson said late Tuesday that it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling faulty implants that led to injuries and additional surgeries.

Metal-on-metal hip replacement patients at no more risk of developing cancer

April 3, 2012
Patients who have had metal-on-metal hip replacements are no more likely to develop cancer in the first seven years after surgery than the general population, although a longer-term study is required, a study published in ...

More data on knee replacements needed

March 7, 2012
(Medical Xpress) -- Oxford University experts have called for better monitoring of knee replacement surgery to improve outcomes for patients.

Latest data confirms high failure rates for metal-on-metal hip replacements

March 12, 2012
Ten days after the Medicines and Healthcare products Regulatory Agency (MHRA) announced that patients who have received stemmed metal-on-metal (MOM) hip replacements will need annual check-ups, The Lancet publishes "unequivocal ...

Evidence for the long-term safety and effectiveness of millions of knee replacement implants lacking

March 5, 2012
Knee replacement is amongst the most common surgical procedures in developed countries, with over 650 000 total knee replacements (TKR) performed in the USA in 2008 alone, at a cost of more than $10 billion. Yet there is ...

Recommended for you

Drug may help surgical patients stop opioids sooner

December 13, 2017
(HealthDay)—Opioid painkillers after surgery can be the first step toward addiction for some patients. But a common drug might cut the amount of narcotics that patients need, a new study finds.

Children best placed to explain facts of surgery to patients, say experts

December 13, 2017
Getting children to design patient information leaflets may improve patient understanding before they have surgery, finds an article in the Christmas issue of The BMJ.

Burn victim saved by skin grafts from identical twin (Update)

November 23, 2017
A man doomed to die after suffering burns across 95 percent of his body was saved by skin transplants from his identical twin in a world-first operation, French doctors said Thursday.

Is a common shoulder surgery useless?

November 21, 2017
(HealthDay)—New research casts doubt on the true effectiveness of a common type of surgery used to ease shoulder pain.

Study shows electric bandages can fight biofilm infection, antimicrobial resistance

November 6, 2017
Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic ...

Obesity increases incidence, severity, costs of knee dislocations

November 3, 2017
A new study of more than 19,000 knee dislocation cases in the U.S. between 2000 and 2012 provides a painful indication of how the nation's obesity epidemic is changing the risk, severity and cost of a traumatic injury.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.